Lactucopicrin ameliorates oxidative stress mediated by scopolamine-induced neurotoxicity through activation of the NRF2 pathway

Neurochemistry International

Volumn 99, Issue , 2016, Pages 133-146

  Venkatesan, Ramu ^a   Subedi, Lalita ^a   Yeo, Eui Ju ^a   Kim, Sun Yeou ^a  

^a Gachon University   (South Korea)

Author keywords

AChE inhibitors; Antioxidant; Lactucopicrin; NRF2; ROS; Scopolamine

Indexed keywords

CASPASE 3; CATALASE; CYTOCHROME C; GLUTATHIONE PEROXIDASE; LACTUCOPICRIN; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE; SCOPOLAMINE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; INTYBIN; LACTONE; MUSCARINIC RECEPTOR BLOCKING AGENT; NFE2L2 PROTEIN, RAT; SCOPOLAMINE BROMIDE; SESQUITERPENE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; GLIOMA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SCOPOLAMINE INDUCED NEUROTOXICITY; ANIMAL; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LACTONES; MUSCARINIC ANTAGONISTS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; SCOPOLAMINE HYDROBROMIDE; SESQUITERPENES; SIGNAL TRANSDUCTION;

EID: 84979081106     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2016.06.010     Document Type: Article

References (64)

1. Aebi, H., Catalase in vitro. Methods Enzym. 105 (1984), 121–125.
2. Ahn, Y.J., Park, S.J., Woo, H., Lee, H.E., Kim, H.J., Kwon, G., Gao, Q., Jang, D.S., Ryu, J.H., Effects of allantoin on cognitive function and hippocampal neurogenesis. Food Chem. Toxicol. 64 (2014), 210–216.
3. Bajo, R., Pusil, S., López, M., Canuet, L., Pereda, E., Osipova, D., Maestú, F., Pekkonen, E., Scopolamine effects on functional brain connectivity: a pharmacological model of Alzheimer's disease. Sci. Rep., 5, 2015, 9748.
4. Barak, S., Weiner, I., Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs. Int. J. Neuropsychopharmacol. 12 (2009), 227–241.
5. Blennow, K., Mattsson, N., Schöll, M., Hansson, O., Zetterberg, H., Amyloid biomarkers in Alzheimer's disease. Trends Pharmacol. Sci 36:5 (2015), 297–309.
6. Brookmeyer, R., Johnson, E., Ziegler-Graham, K., Arrighi, H.M., Forecasting the global burden of Alzheimer's disease. Alzheimer's Dementia 3 (2007), 186–191.
7. Chen, M.-H., Tsai, C.-F., Hsu, Y.-W., Lu, F.-J., Epigallocatechin gallate eye drops protect against ultraviolet B–induced corneal oxidative damage in mice. Mol. Vis., 20, 2014, 153.
8. Chen, W., Cheng, X., Chen, J., Yi, X., Nie, D., Sun, X., Qin, J., Tian, M., Jin, G., Zhang, X., Lycium barbarum polysaccharides prevent memory and neurogenesis impairments in scopolamine-treated rats. PLoS One, 9, 2014, e88076.
9. Choi, J.H., Lee, J.Y., Choi, A.-Y., Hwang, K.-Y., Choe, W., Yoon, K.-S., Ha, J., Yeo, E.-J., Kang, I., Apicidin induces endoplasmic reticulum stress-and mitochondrial dysfunction-associated apoptosis via phospholipase Cγ1-and Ca2+-dependent pathway in mouse Neuro-2a neuroblastoma cells. Apoptosis 17 (2012), 1340–1358.
10. Crapper, D., DeBoni, U., Brain aging and Alzheimer's disease. Can. Psychiatric Assoc. J./La Revue de l'Association des psychiatres du Canada, 1978, 23(4), 229–233.
11. Dzamba, D., Harantova, L., Butenko, O., Anderova, M., Glial cells-the key elements of Alzheimer’ s disease. Curr. Alzheimer Res. 13:8 (2016), 894–911.
12. Ghezzi, L., Scarpini, E., Galimberti, D., Disease-modifying drugs in Alzheimer's disease. Drug Des. Dev. Ther., 7, 2013, 1471.
13. Godyń, J., Jończyk, J., Panek, D., Malawska, B., Therapeutic strategies for Alzheimer's disease in clinical trials. Pharmacol. Rep. 68 (2016), 127–138.
14. Grimm, A., Mensah-Nyagan, A.G., Eckert, A., Alzheimer, mitochondria and gender. Neurosci. Biobehav. Rev., 2016 2016.04.012, (Epub ahead of print).
15. Guan, L., Han, B., Li, Z., Hua, F., Huang, F., Wei, W., Yang, Y., Xu, C., Sodium selenite induces apoptosis by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in human acute promyelocytic leukemia NB4 cells. Apoptosis 14 (2009), 218–225.
16. Guérout, N., Li, X., Barnabé-Heider, F., Cell fate control in the developing central nervous system. Exp. Cell Res. 321 (2014), 77–83.
17. Haerter, F., Eikermann, M., Reversing neuromuscular blockade: inhibitors of the acetylcholinesterase versus the encapsulating agents sugammadex and calabadion. Expert Opin. Pharmacother. 17:6 (2016), 819–833.
18. Harper, M.E., Bevilacqua, L., Hagopian, K., Weindruch, R., Ramsey, J., Ageing, oxidative stress, and mitochondrial uncoupling. Acta Physiol. Scand. 182 (2004), 321–331.
19. Hasselmann, H., Scopolamine and depression: a role for muscarinic antagonism?. CNS Neurological Disorders-Drug Targets (Formerly Curr. Drug Targets-CNS Neurological Disord.) 13 (2014), 673–683.
20. Hilgetag, C.C., Barbas, H., Are there ten times more glia than neurons in the brain?. Brain Struct. Funct. 213 (2009), 365–366.
21. Hou, X., Tong, Q., Wang, W., Xiong, W., Shi, C., Fang, J., Dihydromyricetin protects endothelial cells from hydrogen peroxide-induced oxidative stress damage by regulating mitochondrial pathways. Life Sci. 130 (2015), 38–46.
22. Hu, X.-L., Niu, Y.-X., Zhang, Q., Tian, X., Gao, L.-Y., Guo, L.-P., Meng, W.-H., Zhao, Q.-C., Neuroprotective effects of Kukoamine B against hydrogen peroxide-induced apoptosis and potential mechanisms in SH-SY5Y cells. Environ. Toxicol. Pharmacol. 40 (2015), 230–240.
23. Hutson, P., Finger, E., Magliaro, B., Smith, S., Converso, A., Sanderson, P., Mullins, D., Hyde, L., Eschle, B., Turnbull, Z., The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S, 4S)-4-methyl-1-(pyrimidin-2-ylmethyl) pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1, 5-dihydro-4H-pyrazolo [3, 4-d] pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents. Neuropharmacology 61 (2011), 665–676.
24. Jahanshahi, M., Nickmahzar, E., Babakordi, F., The effect of Ginkgo biloba extract on scopolamine-induced apoptosis in the hippocampus of rats. Anatomical Sci. Int. 88 (2013), 217–222.
25. Jang, J.H., Kim, C.Y., Lim, S.H., Yang, C.H., Song, K.S., Han, H.S., Lee, H.K., Lee, J., Neuroprotective effects of Triticum aestivum L. against β-Amyloid-induced cell death and memory impairments. Phytother. Res. 24 (2010), 76–84.
26. Jiang, W., Luo, T., Li, S., Zhou, Y., Shen, X.-Y., He, F., Xu, J., Wang, H.-Q., Quercetin protects against okadaic acid-induced injury via MAPK and PI3K/Akt/GSK3β signaling pathways in HT22 hippocampal neurons. PLoS One, 11, 2016, e0152371.
27. Kang, J.-M., Ju, H.-L., Sohn, W.-M., Na, B.-K., Characterization of biochemical properties of a selenium-independent glutathione peroxidase of Cryptosporidium parvum. Parasitology 141 (2014), 570–578.
28. Kang, T.H., Moon, E., Hong, B.N., Choi, S.Z., Son, M., Park, J.-H., Kim, S.Y., Diosgenin from Dioscorea nipponica ameliorates diabetic neuropathy by inducing nerve growth factor. Biol. Pharm. Bull. 34 (2011), 1493–1498.
29. Kanthasamy, A.G., Kitazawa, M., Yang, Y., Anantharam, V., Kanthasamy, A., Environmental neurotoxin dieldrin induces apoptosis via caspase-3-dependent proteolytic activation of protein kinase C delta (PKCdelta): implications for neurodegeneration in Parkinson's disease. Mol. Brain, 1, 2008, 12.
30. Kása, P., Rakonczay, Z., Gulya, K., The cholinergic system in Alzheimer's disease. Prog. Neurobiol. 52 (1997), 511–535.
31. Kim, C.-Y., Lee, G.-Y., Park, G.H., Lee, J., Jang, J.-H., Protective effect of arabinoxylan against scopolamine-induced learning and memory impairment. Biomol. Ther., 22, 2014, 467.
32. Kim, D.-H., Ryu, J.-H., Differential effects of scopolamine on memory processes in the object recognition test and the Morris water maze test in mice. Biomol. Ther. 16 (2008), 173–178.
33. Kim, M.H., Kim, S., Yang, W.M., Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimerʼs disease. Planta Med. 80 (2014), 1249–1258.
34. Konar, A., Shah, N., Singh, R., Saxena, N., Kaul, S.C., Wadhwa, R., Thakur, M.K., Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PLoS One, 6, 2011, e27265.
35. Kwon, S.-H., Ma, S.-X., Joo, H.-J., Lee, S.-Y., Jang, C.-G., Inhibitory effects of Eucommia ulmoides Oliv. Bark on scopolamine-induced learning and memory deficits in mice. Biomol. Ther. 21 (2013), 462–469.
36. Laufs, T.L., Wystub, S., Reuss, S., Burmester, T., Saaler-Reinhardt, S., Hankeln, T., Neuron-specific expression of neuroglobin in mammals. Neurosci. Lett. 362 (2004), 83–86.
37. Lee, B., Sur, B., Shim, I., Lee, H., Hahm, D.-H., Phellodendron amurense and its major alkaloid compound, berberine ameliorates scopolamine-induced neuronal impairment and memory dysfunction in rats. Korean J. Physiol. Pharmacol. 16 (2012), 79–89.
38. Lee, J.-S., Kim, H.-G., Han, J.-M., Kim, D.-W., Yi, M.-H., Son, S.-W., Kim, Y.-A., Lee, J.-S., Choi, M.-K., Son, C.-G., Ethanol extract of Astragali Radix and Salviae Miltiorrhizae Radix, Myelophil, exerts anti-amnesic effect in a mouse model of scopolamine-induced memory deficits. J. Ethnopharmacol. 153 (2014), 782–792.
39. Lee, Y.J., Hoe, K.L., Maeng, P.J., Yeast cells lacking the CIT1-encoded mitochondrial citrate synthase are hypersusceptible to heat-or aging-induced apoptosis. Mol. Biol. Cell 18 (2007), 3556–3567.
40. León, R., Garcia, A.G., Marco-Contelles, J., Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease. Med. Res. Rev. 33 (2013), 139–189.
41. Li, G., Kim, C., Kim, J., Yoon, H., Zhou, H., Kim, J., Common pesticide, dichlorodiphenyltrichloroethane (DDT), increases amyloid-β levels by impairing the function of ABCA1 and IDE: implication for Alzheimer's disease. J. Alzheimer's Dis. 46:1 (2015), 109–122.
42. Marcus, D.L., Thomas, C., Rodriguez, C., Simberkoff, K., Tsai, J.S., Strafaci, J.A., Freedman, M.L., Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp. Neurol. 150 (1998), 40–44.
43. Moon, E., Lee, S.O., Kang, T.H., Kim, H.J., Choi, S.Z., Son, M.-W., Kim, S.Y., Dioscorea extract (DA-9801) modulates markers of peripheral neuropathy in type 2 diabetic db/db mice. Biomol. Ther. 22 (2014), 445–452.
44. Moosavi, M., Khales, G.Y., Abbasi, L., Zarifkar, A., Rastegar, K., Agmatine protects against scopolamine-induced water maze performance impairment and hippocampal ERK and Akt inactivation. Neuropharmacology 62 (2012), 2018–2023.
45. Murray, A.P., Faraoni, M.B., Castro, M.J., Alza, N.P., Cavallaro, V., Natural AChE inhibitors from plants and their contribution to Alzheimer's disease therapy. Curr. Neuropharmacol., 11, 2013, 388.
46. Ni, N., Liu, Q., Ren, H., Wu, D., Luo, C., Li, P., Wan, J.-B., Su, H., Ginsenoside Rb1 protects rat neural progenitor cells against oxidative injury. Molecules 19 (2014), 3012–3024.
47. Nicholson, K.M., Anderson, N.G., The protein kinase B/Akt signalling pathway in human malignancy. Cell. Signal. 14 (2002), 381–395.
48. Ogawa, S., Nutritional management of older adults with cognitive decline and dementia. Geriatr. Gerontol. Int. 14 (2014), 17–22.
49. Pandareesh, M., Anand, T., Neuromodulatory propensity of Bacopa monniera against scopolamine-induced cytotoxicity in PC12 cells via down-regulation of AChE and up-regulation of BDNF and muscarnic-1 receptor expression. Cell. Mol. Neurobiol. 33 (2013), 875–884.
50. Rollinger, J., Mock, P., Zidorn, C., Ellmerer, E., Langer, T., Stuppner, H., Application of the in combo screening approach for the discovery of non-alkaloid acetylcholinesterase inhibitors from Cichorium intybus. Curr. Drug Discov. Technol. 2 (2005), 185–193.
51. Rönnbäck, A., Pavlov, P., Mansory, M., Gonze, P., Marlière, N., Winblad, B., Graff, C., Behbahani, H., Mitochondrial dysfunction in a transgenic mouse model expressing human amyloid precursor protein (APP) with the Arctic mutation. J. Neurochem. 136:3 (2016), 497–502.
52. Schmitt, K., Grimm, A., Kazmierczak, A., Strosznajder, J.B., Götz, J., Eckert, A., Insights into mitochondrial dysfunction: aging, amyloid-β, and tau–a deleterious trio. Antioxid. Redox Signal. 16 (2012), 1456–1466.
53. Shulman, R.G., Rothman, D.L., Behar, K.L., Hyder, F., Energetic basis of brain activity: implications for neuroimaging. Trends Neurosci. 27 (2004), 489–495.
54. Tao, L., Xie, J., Wang, Y., Wang, S., Wu, S., Wang, Q., Ding, H., Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H 2 O 2-induced cytotoxicity in PC12 cells. Bioorg. Med. Chem. Lett. 24 (2014), 5385–5389.
55. Tohgi, H., Abe, T., Kimura, M., Saheki, M., Takahashi, S., Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. J. Neural Transm. 103 (1996), 1211–1220.
56. Wang, P., Wingnang Leung, A., Xu, C., Low-intensity ultrasound-induced cellular destruction and autophagy of nasopharyngeal carcinoma cells. Exp. Ther. Med. 2 (2011), 849–852.
57. Weinreb, O., Amit, T., Bar-Am, O., BH Youdim, M., Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment. Curr. Drug targets 13 (2012), 483–494.
58. Wesołowska, A., Nikiforuk, A., Michalska, K., Kisiel, W., Chojnacka-Wójcik, E., Analgesic and sedative activities of lactucin and some lactucin-like guaianolides in mice. J. Ethnopharmacol. 107 (2006), 254–258.
59. Woo, K.W., Kwon, O.W., Kim, S.Y., Choi, S.Z., Son, M.W., Kim, K.H., Lee, K.R., Phenolic derivatives from the rhizomes of Dioscorea nipponica and their anti-neuroinflammatory and neuroprotective activities. J. Ethnopharmacol. 155 (2014), 1164–1170.
60. Xiong, W., Garfinkel, A.E.M., Li, Y., Benowitz, L.I., Cepko, C.L., NRF2 promotes neuronal survival in neurodegeneration and acute nerve damage. J. Clin. Investig., 125, 2015 0–0.
61. Yamazaki, M., Hirakura, K., Miyaichi, Y., Imakura, K., Kita, M., Chiba, K., Mohri, T., Effect of polyacetylenes on the neurite outgrowth of neuronal culture cells and scopolamine-induced memory impairment in mice. Biol. Pharm. Bull. 24 (2001), 1434–1436.
62. Yegambaram, M., Manivannan, B., Beach, T.G., Halden, R.U., Role of environmental contaminants in the etiology of Alzheimer's disease: a review. Curr. Alzheimer Res. 12 (2015), 116–146.
63. Youdim, M.B., Fridkin, M., Zheng, H., Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases. Mech. Ageing Dev. 126 (2005), 317–326.
64. Yuhai, G., Zhen, Z., Significance of the changes occurring in the levels of interleukins, SOD and MDA in rat pulmonary tissue following exposure to different altitudes and exposure times. Exp. Ther. Med. 10 (2015), 915–920.